Series A1 unread notifications
Vineeta Agarwala leads a16z Bio + Health investments in biotechnology, life sciences software and digital health, emphasizing technology and data that improve medicines and care.
Vineeta Agarwala leads a16z Bio + Health investments in biotechnology, life sciences software and digital health, emphasizing technology and data that improve medicines and care.
Career
Vineeta Agarwala holds a BS, Biophysics from Stanford University and a PhD in Biophysics (2013); MD (2015) from Harvard University.
THIndependent Board Director at Tenet Healthcare from 2023-12 to Present
NVBoard Chair and Board Member at National Venture Capital Association from 2021-04 to PresentServes as Board Chair after joining the NVCA board in 2021.
HMCommittee Member, Committee to Visit HMS and HSDM at Harvard Medical School from 2021-04 to PresentServes on the committee that visits Harvard Medical School and the Harvard School of Dental Medicine.
General Partner, Bio + Health at Andreessen Horowitz (a16z) from 2020-01 to PresentInvests in biotech, digital health, life-sciences tools, and diagnostics.
Adjunct Clinical Assistant Professor at Stanford University from 2020 to PresentProvides clinical care in primary care and population health, including cancer-survivorship consultations.
Venture Partner, Life Sciences at Google Ventures from 2015-03 to 2019-12Invested in data-driven biotechnology companies on GV's life-sciences team.
Director of Product Management at Flatiron Health from 2016-08 to 2018-06Led the Foundation Medicine partnership connecting treatment records and tumor-sequencing data for oncology research.BIMD/PhD Researcher at Broad Institute from 2008 to 2015Studied the genetic causes of common human diseases, including population genetics, next-generation sequencing, and clinical translation.
Data Scientist at Kyruus Health from 2010-11 to 2012-03Worked on data products for patient access and referral management.
Business Analyst at McKinsey & Company from 2007 to 2008Consulted for biotechnology, pharmaceutical and medical-device companies.Investing Announcements
Series A
Series ACosigns Received
Krishna YeshwantManaging Partner at GV
We are all grateful for her contributions @GVteam and her impact on many companies.
Vijay PandeScientist, entrepreneur, and life-sciences investor
Vineeta has uniquely pierced through the complexities of both, understanding people and organizations just as much as she does math and science.